$98.98
3.43% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
US42226A1079
Symbol
HQY

HealthEquity Inc Target price 2024 - Analyst rating & recommendation

HealthEquity Inc Classifications & Recommendation:

Buy
93%
Hold
7%

HealthEquity Inc Price Target

Target Price $106.79
Price $98.98
Potential
Number of Estimates 14
14 Analysts have issued a price target HealthEquity Inc 2025 . The average HealthEquity Inc target price is $106.79. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 15 analysts: 14 Analysts recommend HealthEquity Inc to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the HealthEquity Inc stock has an average upside potential 2025 of . Most analysts recommend the HealthEquity Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jan '24 2025
Estimates
Revenue Billion $ 1.00 1.18
16.00% 18.39%
EBITDA Margin 28.13% 40.29%
21.92% 43.21%
Net Margin 5.59% 9.18%
277.98% 64.20%

13 Analysts have issued a sales forecast HealthEquity Inc 2025 . The average HealthEquity Inc sales estimate is

$1.2b
Unlock
. This is
7.67% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.2b 9.62%
Unlock
, the lowest is
$1.2b 6.89%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $1,000m 16.00%
2025
$1.2b 18.39%
Unlock
2026
$1.3b 11.16%
Unlock
2027
$1.5b 11.53%
Unlock

13 Analysts have issued an HealthEquity Inc EBITDA forecast 2025. The average HealthEquity Inc EBITDA estimate is

$477m
Unlock
. This is
41.30% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$497m 47.37%
Unlock
, the lowest is
$469m 38.84%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $281m 41.42%
2025
$477m 69.55%
Unlock
2026
$552m 15.69%
Unlock
2027
$654m 18.62%
Unlock

EBITDA Margin

2024 28.13% 21.92%
2025
40.29% 43.21%
Unlock
2026
41.93% 4.07%
Unlock
2027
44.60% 6.37%
Unlock

10 HealthEquity Inc Analysts have issued a net profit forecast 2025. The average HealthEquity Inc net profit estimate is

$109m
Unlock
. This is
3.68% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$128m 22.50%
Unlock
, the lowest is
$101m 3.55%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $55.9m 306.45%
2025
$109m 94.40%
Unlock
2026
$156m 43.21%
Unlock
2027
$222m 42.49%
Unlock

Net Margin

2024 5.59% 277.98%
2025
9.18% 64.20%
Unlock
2026
11.83% 28.87%
Unlock
2027
15.11% 27.73%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Jan '24 2025
Estimates
Earnings Per Share $ 0.64 1.24
306.45% 93.75%
P/E 79.56
EV/Sales 8.01

10 Analysts have issued a HealthEquity Inc forecast for earnings per share. The average HealthEquity Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$1.24
Unlock
. This is
3.33% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$1.47 22.50%
Unlock
, the lowest is
$1.16 3.33%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.64 306.45%
2025
$1.24 93.75%
Unlock
2026
$1.78 43.55%
Unlock
2027
$2.54 42.70%
Unlock

P/E ratio

Current 82.46 82.29%
2025
79.56 3.52%
Unlock
2026
55.55 30.18%
Unlock
2027
38.99 29.81%
Unlock

Based on analysts' sales estimates for 2025, the HealthEquity Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.62 23.32%
2025
8.01 7.13%
Unlock
2026
7.20 10.04%
Unlock
2027
6.46 10.34%
Unlock

P/S ratio

Current 7.86 24.85%
2025
7.30 7.13%
Unlock
2026
6.57 10.04%
Unlock
2027
5.89 10.34%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today